Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis | MicrobiomeTrials← Back to trialsNCT07595900
Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2028-10-30
Enrollment target: 31 participants Other microbiome trials you might be interested in
Granulomatous MastitisMastitis Chronic
The goal of this observational study is to investigate the disease progression rate and timing in patients with mild Non…
Guangzhou, ChinaCompleted Jan 30, 2026
Granulomatous MastitisMastitis Chronic
The purpose of this study is to evaluate the validity and reliability of the Mastitis-score (M-score) and the Breast Inf…
Chaozhou, ChinaEst. completion May 26, 2026